−75.23 USD
−8.32 M USD
0.00 USD
23.78 M
About TuHURA Biosciences, Inc.
Sector
Industry
CEO
James A. Bianco
Website
Headquarters
Tampa
FIGI
BBG001J7N7K8
TuHURA Biosciences, Inc. is a phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company is headquartered in Tampa, FL.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of HURA is 3.76 USD — it has increased by 1.82% in the past 24 hours. Watch TuHURA Biosciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange TuHURA Biosciences, Inc. stocks are traded under the ticker HURA.
HURA stock has fallen by −29.52% compared to the previous week, the month change is a −34.95% fall, over the last year TuHURA Biosciences, Inc. has showed a −69.37% decrease.
We've gathered analysts' opinions on TuHURA Biosciences, Inc. future price: according to them, HURA price has a max estimate of 15.00 USD and a min estimate of 15.00 USD. Watch HURA chart and read a more detailed TuHURA Biosciences, Inc. stock forecast: see what analysts think of TuHURA Biosciences, Inc. and suggest that you do with its stocks.
HURA reached its all-time high on Jun 15, 2016 with the price of 190,225.00 USD, and its all-time low was 2.84 USD and was reached on Mar 12, 2024. View more price dynamics on HURA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
HURA stock is 15.47% volatile and has beta coefficient of −0.12. Track TuHURA Biosciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is TuHURA Biosciences, Inc. there?
Today TuHURA Biosciences, Inc. has the market capitalization of 141.65 M, it has decreased by −28.72% over the last week.
Yes, you can track TuHURA Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
HURA earnings for the last quarter are −1.40 USD per share, whereas the estimation was −9.10 USD resulting in a 84.62% surprise. The estimated earnings for the next quarter are −3.50 USD per share. See more details about TuHURA Biosciences, Inc. earnings.
HURA net income for the last quarter is −2.32 M USD, while the quarter before that showed −2.01 M USD of net income which accounts for −15.56% change. Track more TuHURA Biosciences, Inc. financial stats to get the full picture.
No, HURA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 23, 2024, the company has 11.00 employees. See our rating of the largest employees — is TuHURA Biosciences, Inc. on this list?
Like other stocks, HURA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TuHURA Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TuHURA Biosciences, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TuHURA Biosciences, Inc. stock shows the sell signal. See more of TuHURA Biosciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.